Feedback
  • Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated…

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
He, Jinbiao;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Yang, Yu;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Zhang, Fan;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Li, Yanjuan;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Li, Xiaosi;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Pu, Xuemei;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
He, Xudong;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Zhang, Mei;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Yang, Xinxing;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Yu, Qiuman;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Qi, Yan;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Li, Xuefang;
Affiliation
College of Pharmaceutical Science ,School of Clinical Medicine ,Yunnan Key Laboratory of Southern Medicinal Utilization ,Yunnan University of Chinese Medicine ,Kunming ,China
Yu, Jie

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (19.05.2023)
Volume:
14
Date Issued:
19.05.2023
DOI:
10.3389/fphar.2023.1172950
Language:
English
Type of Resource:
Text
Keywords:
MAFLD (metabolic-associated fatty liver disease); Poria cocos (Schw.) Wolf.; bile acid metabolism; FXR/PPARα-SREBP pathway; lipid homeostasis; UPLC Q-TOF/MS
Subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 He, Yang, Zhang, Li, Li, Pu, He, Zhang, Yang, Yu, Qi, Li and Yu.

Use and reproduction: